title: Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting.
authors.affiliation: National Amyloidosis Centre, University College London Medical School, UK Cross Cancer Institute, University of Alberta, Edmonton, Canada.
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Venner
authors.affiliation: National Amyloidosis Centre, University College London Medical School, UK.
authors.forename: Julian D
authors.initials: JD
authors.lastname: Gillmore
authors.affiliation: National Amyloidosis Centre, University College London Medical School, UK.
authors.forename: Sajitha
authors.initials: S
authors.lastname: Sachchithanantham
authors.affiliation: National Amyloidosis Centre, University College London Medical School, UK.
authors.forename: Shameem
authors.initials: S
authors.lastname: Mahmood
authors.affiliation: National Amyloidosis Centre, University College London Medical School, UK.
authors.forename: Thirusha
authors.initials: T
authors.lastname: Lane
authors.affiliation: National Amyloidosis Centre, University College London Medical School, UK.
authors.forename: Darren
authors.initials: D
authors.lastname: Foard
authors.affiliation: Hématologie Clinique, CHU Purpan, Toulouse, France.
authors.forename: Murielle
authors.initials: M
authors.lastname: Roussel
authors.affiliation: National Amyloidosis Centre, University College London Medical School, UK.
authors.forename: Lisa
authors.initials: L
authors.lastname: Rannigan
authors.affiliation: National Amyloidosis Centre, University College London Medical School, UK Central Manchester University Hospital, Department of Clinical Haematology, Manchester, UK.
authors.forename: Simon Dj
authors.initials: SDj
authors.lastname: Gibbs
authors.affiliation: National Amyloidosis Centre, University College London Medical School, UK.
authors.forename: Jennifer H
authors.initials: JH
authors.lastname: Pinney
authors.affiliation: National Amyloidosis Centre, University College London Medical School, UK.
authors.forename: Carol J
authors.initials: CJ
authors.lastname: Whelan
authors.affiliation: National Amyloidosis Centre, University College London Medical School, UK.
authors.forename: Helen J
authors.initials: HJ
authors.lastname: Lachmann
authors.affiliation: National Amyloidosis Centre, University College London Medical School, UK.
authors.forename: Philip N
authors.initials: PN
authors.lastname: Hawkins
authors.affiliation: National Amyloidosis Centre, University College London Medical School, UK a.wechalekar@ucl.ac.uk.
authors.forename: Ashutosh D
authors.initials: AD
authors.lastname: Wechalekar
mesh_terms: D000328:Adult; D000368:Aged; D000686:Amyloidosis / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015331:Cohort Studies; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007147:Immunoglobulin Light Chains; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D018579:Patient Selection; D011379:Prognosis; D015996:Survival Rate; D014182:Transplantation, Autologous
chemical_list: D007147:Immunoglobulin Light Chains
keywords: amyloidosis; patient selection; stem cell transplantation